Stay updated on Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page.

Latest updates to the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check46 days agoChange DetectedThe page has undergone significant content changes, particularly the removal of detailed information regarding a clinical trial for ZX008 (fenfluramine hydrochloride) in treating Dravet syndrome, including key inclusion and exclusion criteria. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference21%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check61 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check97 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of ZX008 Oral Solution in Dravet Syndrome Clinical Trial page.